Skip to main content
Veterinary Medicines

KANACILL FORTIUS

Authorised
  • Kanamycin sulfate

Product identification

Medicine name:
KANACILL FORTIUS
Active substance:
  • Kanamycin sulfate
Target species:
  • Cattle
  • Chicken
  • Pig
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Kanamycin sulfate
    150000.00
    international unit(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Meat and offal
        64
        day
      • Milk
        108
        hour
    • Chicken
      • Meat and offal
        37
        day
    • Pig
      • Meat and offal
        64
        day
  • Subcutaneous use
    • Cattle
      • Meat and offal
        64
        day
    • Chicken
      • Meat and offal
        37
        day
    • Pig
      • Meat and offal
        64
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01GB04
Authorisation status:
  • Valid
Authorised in:
  • Italy
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Intervet Productions S.r.l.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet Productions S.r.l.
Responsible authority:
  • Ministry Of Health
Authorisation number:
This information is not available for this product.
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Italian (PDF)
Published on: 3/06/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."